Alzheon launches and secures backing
Alzheon, a clinical-stage biopharmaceutical company focused on brain health, memory and aging has launched. The company has secured initial financing from strong private investors with long-term vision and a history of exceptional success in building biopharmaceutical companies. Alzheon is located in Lexington, Massachusetts, USA.
23 October 2013•4 mins read
